Comformity Analysis of Real Cost to INA-CBG'S Cost in Non Hemorrhagic Stroke Treatment Of Hospitalized JKN Patients at Dr. Soehadi Prijonegoro Hospital Sragen 2015

Abstract

Stroke is one of the degenerative diseases and is also the number one cause of death in Indonesia. Enforcement INA-CBGs (Indonesia Case Based Groups) on the financing of the hospital for stroke patients in need of treatment planning and cost analysis for a costly stroke so that the hospital can make cost savings and is expected to be a solution in controlling health care costs. The purpose of this study was to determine treatment pattern of non-hemorrhagic stroke, correlation between real cost to INA-CBG's cost, and factors affecting the real cost.

This study was an observational research, the data was taken retrospectively from the document of national health insurance claim in January-June 2015 period. The descriptive analysis is used for patient characteristic and real cost, the data analysis was conducted using one sample t-test to compare the real cost and INA-CBG’s tariff, correlational test to find out the factors affecting the real cost.

The results showned that treatment pattern were citicoline (35,31 %), clopidogrel (26,02 %), amlodipin (7,06 %), simvastatin (5,20 %). Analysis using one sample t-test obtained severity I treatment class 3 Rp. 1.066.143,-, severity II treatment class 3 Rp. 766.848,-, dan severity III treatment class 3 Rp. 931.119,-. Factors that affect were secondary diagnosis, severity, treatment class and LOS.